Covishield At Rs 400 A Dose For States, 600 For Private Hospitals: Serum Institute Of India

Its vaccines will still be more affordable than foreign jabs, which are priced from Rs 750 to Rs 1,500 a shot, Serum said.

Days ahead of a new round of vaccinations from May 1 that will include all above 18, the Serum Institute of India (SII) today announced that covishield will be sold at Rs 400 a shot to states and Rs 600 to private hospitals.

The centre will continue to receive Covishield doses at Rs 150 each, which means it will be cheapest to get a vaccine shot from central government hospitals or establishments

Its vaccines will still be more affordable than foreign jabs, which are priced from Rs 750 to Rs 1,500 a shot, Serum said.

50 per cent of the vaccine doses, as per the government’s policy, will be reserved for the centre and the rest will be divided between states and private hospitals.

Stressing that supplying the vaccine independently to corporates would be challenging, Serum urged companies and individuals to access the shots through states and private hospitals.

“…owing to the complexity, and urgency of the situation it is challenging to supply it independently to each corporate entity,” Serum said in its statement.

“We would urge all corporate and private individuals to access the vaccines through the state facilitated machinery and private health systems.”

An additional 1.2 million doses will be needed when vaccination drive, carried out in stages since January, open to all adults.

The government has announced Rs 4,500 crore aid to vaccine-makers Serum and Bharat Biotech. Serum chief Adar Poonawalla says a ramp-up will start immediately and by the end of May, there will be 15 to 20 per cent more doses of Covishield in the market.

Mr Poonawalla, in an interview to NDTV, said the doses would be “evenly split” between states and private suppliers and that prices would vary from the centre to states and private hospitals.

Mr Poonawalla said his company would be able to supply over 100 million doses per month after July.

“We are ramping up immediately and the big ramp-up will happen post-July. But even between now and July we will ramp up 15 to 20 per cent in our monthly capacities. Starting by the end of May, there will be 15-20 per cent more doses in the market. After July, it will be 40 per cent… so after July we will cross 100 million doses per month,” he told NDTV.

Dear Readers,
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.

Related posts